Tenor Capital Management »

Halozyme Therapeutics shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $10B 12M 867.52
2023-09-30 $10B 12M 849.02
2023-06-30 $4.2M 5.0M 0.84

More positions owned by Tenor Capital Management

Palo Alto Networks Note 0.375% 6/0 (Principal)
Insight Enterprises Note 0.750% 2/1 (Principal)
Ziff Davis Note 1.750%11/0 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Block Note 0.125% 3/0 (Principal)
Zscaler Note 0.125% 7/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Alteryx Note 0.500% 8/0 (Principal)
Five9 Note 0.500% 6/0 (Principal)
Mongodb Note 0.250% 1/1 (Principal)
Liberty Media Corp Note 2.750% 12/0 (Principal)
United States Stl Corp Note 5.000%11/0 (Principal)
Ati Note 3.500% 6/1 (Principal)
Evolent Health Note 1.500%10/1 (Principal)
Hubspot Note 0.375% 6/0 (Principal)

View all positions for Tenor Capital Management

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics